Systematische Übersicht
A Review on the Use of Topical Ruxolitinib for the Treatment of Vitiligo
Journal of Drugs in Dermatology · 2023
DOI: 10.36849/jdd.7268 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Drugs in Dermatology, 2023. Verfasst von Meghan C Grossmann und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Vitiligo, Janus Kinase Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
VitiligoJanus Kinase InhibitorsHumansPyrimidinesNitrilesPyrazolesTreatment Outcome
Substanzen
ruxolitinibPyrimidinesNitrilesPyrazolesJanus Kinase Inhibitors
Zitieren
APA
Grossmann, M. C., Haidari, W., & Feldman, S. R. (2023). A Review on the Use of Topical Ruxolitinib for the Treatment of Vitiligo. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7268
Vancouver
Grossmann MC, Haidari W, Feldman SR. A Review on the Use of Topical Ruxolitinib for the Treatment of Vitiligo. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7268
BibTeX
@article{Grossmann2023,
author = {Grossmann, Meghan C and Haidari, Wasim and Feldman, Steven R},
title = {A Review on the Use of Topical Ruxolitinib for the Treatment of Vitiligo},
journal = {Journal of Drugs in Dermatology},
year = {2023},
doi = {10.36849/jdd.7268}
}
EUVIMED